Why the study?
Does sustained-release molsidomine (8 mg) delay the onset of angina and ischemia during exercise in patients with angina of effort?
Does sustained-release molsidomine (8 mg) delay the onset of angina and ischemia during exercise in patients with angina of effort?
Single doses of sustained-release molsidomine (8 mg) and isosorbide dinitrate (20 mg) effectively delay the onset of angina and ECG signs of ischemia for up to 4 hours, but the effect does not persist at 8 hours.
Short-acting nitrate effects last ~4 h but not 8 h; leaves open optimal dosing for sustained antianginal coverage in effort angina.
The effectiveness and duration of the anti-anginal action of two sustained-release preparations, molsidomine (8 mg) and isosorbide dinitrate (20 mg), were assessed by means of serial exercise tests in 12 patients with angina of effort. The tests, which were limited by the symptoms, were carried out on three consecutive days using the Bruce protocol. Each patient was tested four times each day: the first test was performed before treatment and the others were carried out 1, 4 and 8 h after administration of the drug or placebo. One hour after administration of molsidomine, the appearance of signs of ischaemia in the ECG were considerably delayed and they were reduced in magnitude. Furthermore, the length of time during which the patients were free of angina increased. After 4 h both drugs significantly delayed the onset of angina and depression of the ST segment by 1 mm. The conclusion is that at the doses used both drugs prolong the length of time in which there is no angina, but that they have no significant effect at 8 h.
No takes yet. Share an insight, caveat, or question.
Ruano et al. (1988) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: